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Abstract
Background: Cancer and its treatment have a major impact on the lives of patients and their intimate partners,
such as on their health-related quality of life (HRQOL). The aims of this study are to: (i) assess the HRQOL of
advanced cancer patients and spousal caregivers, and explore the relationship between the HRQOL of cancer
patients and that of their spousal caregivers; (ii) detect factors influencing the HRQOL of cancer patients and
spousal caregivers; and (iii) explore the impact of anxiety and depression on the HRQOL of couples.
Methods: A total of 131 couples where one of the partners was hospitalized for advanced cancer were invited to
complete a survey to assess their demographic and background information, HRQOL, and anxiety and depression.
HRQOL was measured using the SF-12, while anxiety and depression were measured using the Hospital Anxiety
and Depression Scale. Data were analyzed using a T-test, Pearson correlations, multiple linear regressions, and
structural equation modeling.
Results: In general, the spousal caregivers had higher levels of HRQOL (seven out of eight SF-12 domains and two
SF-12 dimensions) p = 0.038–0.000, anxiety (p = 0.002), and depression (p = 0.011) than patients. Correlations of
HRQOL between patients and spouses were small to moderate (r = 0.193–0.398). Multiple independent factors
influencing the physical component summary (PCS), mental component summary (MCS), vitality (VT), and role
emotional (RE) sections of the SF-12 were identified, including: gender, time since diagnosis, levels of education,
working status, the extent to which spousal caregivers were informed about the disease, improved marital
relationship after the diagnosis of cancer, and anxiety and depression. For both patients and spousal caregivers, the
strongest independent factor influencing HRQOL (SF-12 PCS, MCS, VT, and RE) was anxiety and depression. Anxiety
and depression may have both actor and partner effects on the HRQOL of couples to various degrees.
Conclusions: The findings of this study call attention to the HRQOL of couples and its influencing factors. Individual
characteristics of cancer patients and spouses, marital relationship, and anxiety and depression are highlighted as areas
in which couples coping with cancer could benefit from interventions to improve their HRQOL.
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Background
Cancers are among the leading causes of morbidity and
mortality worldwide. In 2012, there were 14.1 million
new cases of cancer and 8.2 million deaths from cancer
worldwide. Of these, 21 % of the new cancer cases (3
million) and 27 % of the cancer deaths (2.2 million) oc-
curred in China [1]. The World Health Organization
(WHO) expects the number of new cases of cancer to
rise by about 70 % over the next two decades [1]. It is
unfortunate that in developing countries, where treat-
ment options are both limited and expensive, most new
cases of cancer are frequently diagnosed at the advanced
stage [2]. This late diagnosis of cancer and the limited
treatment options available in developing countries, e.g.,
in China, may lead to poor prognoses for cancer, which
in turn may affect the health-related quality of life
(HRQOL) of cancer patients. This further supports the
argument that more attention should be paid to the
problem of the HRQOL of cancer patients. The chal-
lenges posed by cancer and its treatment are felt not
only by patients but also by the members of their family
[3], particularly by spouses, who are typically the pri-
mary caregivers of cancer patients [4].
Thus, these challenges must be addressed on the indi-
vidual and dyadic levels. A diagnosis of cancer is a crisis
for individuals, who are confronted not only with the
cancer and its treatment, but also faced with the possi-
bility of physical disability, threats to their family and so-
cial roles and relationships, and concerns about life and
death [5]. Spouses also face challenges such as worries
about their ability to provide emotional and practical
support, and the potential loss of their life partner from
cancer [6, 7]. Both patients and their spouses also need
to cope together as dyads along the cancer trajectory.
Couples go through a process of readjusting and adapt-
ing, which includes breaking the “bad news” to other
family members, managing household and childcare re-
sponsibilities, negotiating changes in family and social
roles, and interferences with life plans [6, 8, 9]. A review
of the mutual impact between the spousal caregiver and
the cancer patient revealed that the process of coping
with cancer affects both parties, with reciprocal influ-
ences and congruence between the spousal caregiver-
patient dyads [10].
The challenges posed by the diagnosis and treatment
of cancer, and the changes in the relational dynamics be-
tween cancer patients and their spouses, can have an im-
pact on the HRQOL of both patients and their spouses
[11]. Each partner’s HRQOL can also affect that of the
other [12, 13]. HRQOL is a multidimensional concept
encompassing perceptions of both the negative and posi-
tive aspects of the dimensions of physical, emotional, so-
cial, and cognitive function [14]. In cancer practice, the
measure of HRQOL can supply valuable information on
the health status and effects of treatment on patients
and spousal caregivers [15], and can be adopted in clin-
ical care as a predictor of positive coping [16].
The experience of couples coping with cancer together,
however, is complex and relationships are dynamic [17].
The mutual impact between couples, in terms of
HRQOL, and the factors influencing HRQOL have not
been well delineated, particularly from the perspective of
the dyadic level in mainland China. It is essential to ad-
dress this issue, if the HRQOL of both cancer patients
and their spousal caregivers is to be optimized.
Most studies in this area have focused on the HRQOL
of patients and its influencing factors [18–22]. Various
factors have been reported as influencing the QOL of
patients, including the patients’ socio-demographic char-
acteristics, such as age, gender, working status, family in-
come, level of education [18–21], and symptom distress
(e.g., anxiety and depression) [19, 20, 23, 24]. However,
which factors influence the HRQOL of cancer patients
remains inconclusive. For example, a study on cancer
patients undergoing chemotherapy reported that demo-
graphic variables, e.g., age, education, marital status, or
income, were not significantly related to the QOL of the
patients [22].
A study exploring the factors influencing the QOL of
spousal caregivers in China showed that the QOL of spou-
sal caregivers was associated with demographic character-
istics of the spouses, caregiving-related variables, and the
severity of the patients’ symptoms [25]. However, another
study revealed contradictory results, with gender, level of
education, and time spent on caring found to be not asso-
ciated with the QOL of the family caregivers of cancer pa-
tients [26]. Studies have also revealed that the relationship
between the couples also influences the QOL of the spou-
sal caregivers of cancer patients [26, 27].
There have been very few studies on the factors influ-
encing the HRQOL of couples from the dyadic perspec-
tive. A longitudinal study that assessed the QOL of both
prostate cancer patients and their spouses showed that
better QOL for both partners was associated with the
following factors: a relatively low level of education on
the part of patient, older age on the part of partner, a
higher family income, and localized cancer at baseline
[14]. Another study reported that the overall QOL of both
patients and caregivers was influenced by the following
factors: the cancer diagnosis, length of hospitalization,
caregiving intensity and duration, marital satisfaction, and
caregiving self-esteem [4].
These studies revealed that the factors influencing the
HRQOL of couples coping with cancer potentially include
socio-demographic characteristics, spousal or marital rela-
tionship, and symptoms of distress. Thus, to achieve a bet-
ter understanding of the HRQOL of couples coping with
cancer and the factors influencing it, variables such as the
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characteristics of the patients and spousal caregivers, the
characteristics of the married couples, and their anxiety
and depression were selected as potential influencing fac-
tors in the present study.
To our knowledge, no studies have been conducted in
mainland China assessing the HRQOL and associated fac-
tors of both advanced cancer patients and their spousal
caregivers. Thus, this study is the first of its kind. The spe-
cific objectives of this study are to: (i) assess the HRQOL
of patients with advanced cancer and their spousal care-
givers, and the relationship between the HRQOL of the ad-
vanced cancer patients and that of their spousal caregivers;
(ii) identify factors influencing the HRQOL of advanced
cancer patients and their spousal caregivers; and (iii) ex-
plore the impact of anxiety and depression on the couples’
HRQOL. This study will shed light on the HRQOL of ad-
vanced cancer patients and their spousal caregivers and
their mutual impact, providing evidence for developing in-
terventions to improve the HRQOL of couples.
Methods
Study design and subjects
This was a cross-sectional observational study. Advanced
cancer patients and their spousal caregivers were recruited
from November 2013 to July 2014 from a hospital in the
city of Wuxi, China.
The criteria for couples to be considered for inclusion in
the study were: (i) Chinese adult married couples (age
>18 years old); (ii) a medical diagnosis of any type of ad-
vanced cancer in one partner; (iii) the spouse is the pri-
mary caregiver, who provides informal care to the cancer
patient; (iv) both partners agreed to take part in the study.
The spousal caregiver was defined and identified by the
cancer patient as his or her married partner, and was the
primary source of physical and emotional support since
the diagnosis of cancer. Excluded from the study were
couples with the following characteristics: (i) cancer pa-
tients who had other major health problems, such as de-
mentia; (ii) spousal caregivers who were unable to care for
patients due to chronic illness or who were suffering from
a serious physical or mental illness, including cancer; and
(iii) those who were unable to communicate in Mandarin
(the language commonly spoken in China).
The sample size was calculated using G-power 3.1.9.2,
based on the conventional method of analyzing power
for correlations [28]. Assuming a two-sided type I error
of 5 %, with 90 % power, and a medium effect size (r =
0.30) [29] to detect the resulting correlation in paired
observations (cancer patients and spousal caregivers), it
was estimated that at least 112 dyads would be required.
To ensure an adequate number of samples, 150 couples
were approached.
Of the 150 eligible couples who were approached, 19
declined. The reasons given by the couples for refusing
to participate in the study were that they were not inter-
ested in the study (n = 8), they were too busy (n = 6), or
they did not want to complete a questionnaire (n = 2).
Three couples refused to give a reason. As a result, a
total of 131 couples were included in the study.
Instruments
A questionnaire was compiled based on existing tools,
including the Medical Outcomes Study 12-item Short
Form (MOS SF-12) (version 2) for HRQOL [30] and the
Hospital Anxiety and Depression Scale (HADS) for Anx-
iety and Depression [31].
A demographic and background information sheet was
used to collect information on socio-demographic char-
acteristics and clinical data from both the patients and
their spousal caregivers. The socio-demographic data in-
cluded: age, gender, level of education, working status,
duration of marriage, perceived relationship with one’s
partner before the diagnosis of cancer, if there were per-
ceived changes in the relationship with one’s partner
after the diagnosis of cancer, and if there was a financial
burden on the family due to the cancer-related treat-
ment. The clinical data included: type of cancer, stage of
cancer, time since diagnosis, the extent to which the
couple has been informed about the diagnosis of cancer,
and the amount of time that the spousal caregiver is
spending in caring for the patient (hours/day).
Health-related quality of life (HRQOL) was measured
using the Medical Outcomes Study 12-item Short Form
(MOS SF-12) (version 2) [30]. SF-12 consists of 12 items
making up eight scales that measure the following eight
domains of HRQOL: Physical Functioning (PF), Role-
Physical (RP), Bodily Pain (BP), General Health (GH), Vi-
tality (VT), Role-Emotional (RE), Social Functioning (SF),
and Mental Health (MH). The eight SF-12 domains hypo-
thetically form two dimensions: the Physical Component
Summary (PCS) and the Mental Component Summary
(MCS). The PCS includes the four scales of PF, RP, BP,
and GH; while the MCS contains the other four scales of
VT, RE, SF, and MH [30]. The eight scales and the two di-
mensions were transformed and calculated according to
the SF-12 (version 2) score manual to a scale with a theor-
etical range of 0 to 100 [32]. A higher score indicates a
higher level of HRQOL. The two dimensions (PCS and
MCS) of the SF-12 version 2 achieved R squares of 0.905
with PCS and 0.938 with MCS when the SF-36 was used
in a cross-validated Medical Outcomes Study. Test-retest
(2-week) correlations of 0.89 and 0.76 were observed for
the SF-12 PCS and MCS respectively in the general U.S.
population (n = 232) [30].
The original English version of the SF-36 was translated
and validated in a Chinese population in China [33]. A
health survey study was conducted to determine whether
the SF-12 is an equivalent substitute for the SF-36. The
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Chinese version of the SF-12 (version 2) was established
to be a valid, reliable, and sensitive measurement for
Chinese populations [34]. The Cronbach's alpha of the
Chinese version of the SF-12 was 0.910 in an elderly
Chinese population [35].
The anxiety and depression of the patients and spousal
caregivers were measured using the Hospital Anxiety
and Depression Scale (HADS) [31]. The scale contains
14 items making up two subscales of anxiety and depres-
sion, with seven items in each subscale. A four-point
Likert-type scale (0–3) is used for scoring each item, and
the total score for each subscale is obtained by a simple
summation of the individual items. Scores in each sub-
scale (anxiety and depression) range from 0 to 21. The
higher the scores, the higher the levels of anxiety and
depression. The HADS is a validated and widely used
self-reported measure that assesses individuals’ self-
perceived levels of anxiety and depression. It is used to
identify patients with elevated levels of symptoms and
disorders of anxiety and depression that may be clinic-
ally relevant. The Cronbach’s alpha for HADS anxiety
varied from 0.68 to 0.93 (mean 0.83) and for HADS de-
pression from 0.67 to 0.90 (mean 0.82) [36].
The original English version of HADS was first trans-
lated into Chinese and validated in a Hong Kong popu-
lation [37]. The Chinese version of HADS was proven to
have good linguistic, structural, and scale equivalence
with the original English version [37]. Its sound psycho-
metric properties demonstrated its appropriateness for
use among in-patients [38]. The Cronbach’s alpha for
the Chinese version of HADS was 0.86 for the full scale,
0.82 for the depression subscale, and 0.77 for the anxiety
subscale [38].
The internal consistency of the two translated instru-
ments in this study among cancer patients and spousal
caregivers was acceptable, with a Cronbach’s alpha of
0.81 for SF-12, and a Cronbach’s alpha of 0.85 for both
components of HADS on anxiety and depression in can-
cer patients; and of 0.84 and 0.85 for HADS anxiety and
depression respectively among spousal caregivers.
Data collection procedure
Before the commencement of the study, ethical approval
for the study was granted by the research ethics commit-
tee of Jiangnan University. Informed written consent was
obtained from the participants prior to the study. It was
made clear to them that participation was voluntary and
that they were free to withdraw from the study at any time
for any reason, with no penalty. All of the information
provided by the participants would remain confidential
and their anonymity would be preserved. Only the mem-
bers of the study research team could access the data.
Prior to the commencement of the study, nurses work-
ing in the oncology unit of the study hospital were
provided with explanations of the study and of the in-
struments. The oncologists in the hospital identified
couples in accordance with the eligibility criteria. Cou-
ples who met the criteria for inclusion were approached
in the oncology wards when they were admitted for
chemotherapy treatments. After they were given an ex-
planation of the study and their written informed con-
sent to participate in it was obtained, the couples were
invited to complete the questionnaires separately with
the help of nurses if needed. The questionnaires were
completed in an in-patient private room or nurses’ office,
according to the preference of the couples, in order to
protect their privacy and keep them away from possible
disturbances. The questionnaire took about 10–15 min to
complete. None of the participants reported feeling dis-
comfort or distress while filling out the questionnaire.
Data analysis
The data analysis was performed using the Statistical Pack-
age for the Social Sciences, version 21.0 (SPSS, Chicago,
Illinois, USA). The level of significance was set p < 0.05.
Descriptive statistics such as frequencies, percentages,
means, and standard deviations were used to describe the
characteristics and clinical profile of the participants.
Paired T-test and Pearson correlations were used to com-
pare differences and correlations between the paired vari-
ables of the patients and the spousal caregivers. T-tests,
one-way ANOVAs, and Pearson correlations were per-
formed to examine the associations between different do-
mains or dimensions of the SF-12, including the Physical
and Mental Components Summary, and potential associ-
ated variables, such as gender, age, level of education, type
of cancer, and anxiety and depression. The factors influen-
cing HRQOL were analyzed by multiple linear regressions.
Preparing the data for the multiple linear regressions
involved the following tasks: (1) creating dummy vari-
ables for categorical variables [29], including gender, be-
ing informed about the disease, level of education, and
working status. For example, for the variable gender, the
dummy variable of male vs. female was created by cod-
ing male = 1 and female = 0; (2) extracting the principal
component for related variables to avoid collinearity be-
tween them [29]. For example, to avoid a possible collin-
earity between anxiety and depression with a high
correlation (r = 0.83 for both patients and spousal care-
givers) in this study, the principal component of anxiety
and depression was extracted by conducting a factor
analysis. Thus, HAD (the principal component from a
factor analysis of anxiety and depression - PCFAC) was
used in the following regression analysis.
Structural equation modeling (SEM) guided by the
Actor Partner Interdependence Model (APIM) [39] using
Amos 21.0 was conducted to explore the impact of anxiety
and depression on HRQOL. Thus, APIM analysis was
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used in this study to specify the SEM analysis. The APIM
analysis is considered a versatile approach to modeling
dyadic data [39]. In the APIM, actor effect is the effect of
an individual’s characteristics (e.g., anxiety) on their own
measured outcomes (i.e., PCS); while partner effect refers
to the effect of an individual’s characteristics on the mea-
sured outcomes of their partner. The maximum likelihood
method was applied to estimate the covariance matrices
in all of the selected models. Three indices were used to
evaluate the goodness of fit of the model, namely: Chi-
Square χ2, a confirmatory fit index (CFI), and a root mean
square error of approximation (RMSEA). The level con-
sidered indicative of a good model fit was set at an insig-
nificant p value of p > 0.05 in the Chi-Squareχ2, a value of
above 0.95 in the CFI, and a value of less than 0.08 in the
RMSEA [40].
Results
Table 1 summarizes the characteristics of these couples.
Nearly two thirds of the patients (62.6 %) were male. Al-
though over half of the couples (51.5 %) had been diag-
nosed for less than 6 months, all of the patients were in
the advanced stage of cancer, namely, stage III (n = 56,
42.7 %) and stage IV (n = 75, 57.3 %). More than half of
the patients (55.0 %) suffered from a cancer of the di-
gestive system (e.g., esophageal, gastric, liver, or colorec-
tal cancer). The great majority of patients reported that
they had a “very good” (87.8 %) relationship before the
diagnosis of cancer. Over half of the families (58.8 %) ex-
perienced a serious financial burden due to the cost of
treating the cancer.
HRQOL and HADS correlations and differences between
cancer patients and spousal caregivers
Table 2 shows the mean scores and standard deviations
scores of two dimensions and eight domains of SF-12,
the anxiety and depression scores of HADS, and the cor-
relations and differences between the cancer patients
and spousal caregivers. The results show significant cor-
relations in all paired variables between the patients and
their spousal caregivers, with the exception of the “role
physical” item of SF-12. The effect sizes of the associ-
ation between the patients’ HRQOL and that of their
spouses were small to moderate (r ranged from 0.193 to
0.398). The spousal caregivers had higher scores for
most of the subscales of SF-12 (with the exception of
MCS, SF, and MH), and higher levels of anxiety and de-
pression than the patients.
Table 2 also shows that the scores for vitality (VT,
44.75 ± 8.89 for patients and 47.21 ± 9.61 for spousal
caregivers) were the highest and those for role emotional
(RE, 34.78 ± 10.68 for patients and 38.11 ± 9.95 for spou-
sal caregivers) were the lowest among all of the eight do-
mains of the SF-12. To better understand the HRQOL
of cancer patients and their spousal caregivers, apart
from analyzing SF-12 PCS and MCS as is generally done
[41], in the present study VT and RE with the highest
and lowest scores were selected as the two SF-12 do-
mains used to conduct the following further analysis.
Factors influencing HRQOL
Additional file 1: Table S1 shows associations between
various variables of both patients and spousal caregivers
with the patients’ results in the SF-12 domains of PCS,
MCS, VT, and RE. These variables are listed under the
four sections on the left side of Additional file 1: Table S1
and consist of the patients’ characteristics (S1a), the spou-
sal caregivers’ characteristics (S1b), the dyads’ characteris-
tics (S1c), and the patients’ and spousal caregivers’ HADS
scores (S1d). Additional file 1: Table S2 gives the results of
associations between the variables of both patients and
spousal caregivers with the spousal caregivers’ results in
the SF-12 domains of PCS, MCS, VT, and RE. Again, the
variables on the left side of the table were also organized
under four sections, namely: patients’ characteristics (S2a),
spousal caregivers’ characteristics (S2b), dyads’ characteris-
tics (S2c), and HADS (S2d).
Variables that had significant (p < 0.05) or borderline
(p ≤ 0.086 in this case) significant differences with any of
the four SF-12 scores (PCS, MCS, VT, and RE) in
Additional file 1: Table S1 and Table S2 were further an-
alyzed as independent variables in the next step to iden-
tify the factors influencing HRQOL using multiple linear
regressions. The independent variables that were found
in the previous analysis to be significant included: (1) pa-
tients’ characteristics: gender, time since the diagnosis of
cancer; (2) spousal caregivers’ characteristics: level of
education, time spent by spousal caregivers in caring for
patients per day; (3) dyads’ characteristics: change in the
relationship with their partner after the diagnosis of can-
cer, and financial burden on the family due to the cancer
treatment; (4) HADS: anxiety and depression of both the
patients and their spousal caregivers. The independent
variables that were found in the previous analysis to be
borderline significant included: (1) patients’ characteris-
tics: being informed about the disease (RE, p = 0.086,
PCS, p = 0.084); (2) spousal caregivers’ characteristics:
working status (VT, p = 0.058), being informed about the
disease (RE, p = 0.078).
Table 3 shows the results of the factors associated with
the HRQOL: SF-12 PCS, MCS, VT, and RE scores using
multiple linear regressions in patients. The factors that
were identified included: (3a) patients’ characteristics:
male patients (female spousal caregivers) were associated
with a higher SF-12 VT score (p = 0.029); a longer dur-
ation since the diagnosis of cancer was associated with a
lower SF-12 VT score (p = 0.020); (3b) spousal caregivers’
characteristics: a primary school level of education was
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associated with higher scores for SF-12 MCS (p = 0.019)
and RE (p = 0.003); and a high school level of education
was associated with a higher SF-12 RE-P score (p = 0.036)
when compared with a university level of education or
above. Working status was associated with a higher SF-12
VT score (p = 0.026) than was the case with non-working
status. Compared with being well informed about the
disease, being partly informed about the disease was asso-
ciated with higher scores for SF-12 VT (p = 0.025) and RE
(p = 0.035); (3c) dyads’ characteristics: improved dyadic re-
lationship after the diagnosis of cancer was associated with
a lower SF-12 RE score (p = 0.037) than was the case with
those who saw no change in their relationship with their
partner; and (3d) HADS: a higher level of anxiety and
Table 1 The characteristics of patients and spousal caregivers
Characteristics Patients (P, n=131) Spousal caregivers (SC, n=131)
n (%) n (%)
Age (mean± SD), years 56.6±12.1 (ranging from 25 to 79) 56.0±11.3 (ranging from 29 to 80)
Gender
Male 82 (62.6) 49 (37.4)
Female 49 (37.4) 82 (62.6)
Level of education
Primary school or less 64 (48.9) 67 (51.1)
High school 49 (37.4) 49 (37.4)
University or above 18 (13.7) 15 (11.5)
Working status
Working 75 (57.3) 69 (52.7)
Not working 56 (42.7) 62 (47.3)
The average time since diagnosis/the
duration in their role as a SC
13.7±23.0 months (ranging from 1 to 192 months) <6 months: 67 (51.2)
6 months ~2 years: 43 (32.8)
>2 years ~5 years: 13 (9.9)
>5 years: 8 (6.1)
Couples were informed about the
diseaseb
Partly informed 33 (25.2) 24 (18.3)
Well informed 98 (74.8) 107 (81.7)
Time spent by SC in caring for
patients/day [in hours, n (%)]
<2 hours: 10 (7.6)
2~4 hours: 14 (10.7)
>4~6 hours: 25 (19.1)
>6~8 hours: 21 (16.0)
>8 hours: 61 (46.6)
Types of cancera Digestive system cancer: 72 (55.0); Lung cancer: 35 (26.7);
Urogenital system cancer: 19 (14.5); Others: 5 (3.8)
Dyad Characteristicsc
Duration of marriage (mean± SD), years 30.8±11.6 (ranging from 1–52)
Relationship with their partner before






Change in the relationship with their





No change 93 (71.0)
Financial burden on the family due to
the treatment of cancer
Serious 77 (58.8) Normal 49 (37.4)
Mild or None 5 (3.8)
SD standard deviation
aAll of the patients had advanced cancer, were in stage III (n = 56, 42.7 %) or stage IV (n = 75, 57.3 %); and were receiving chemotherapy
bWell informed: The patient fully understood his/her condition; or the SC was well informed about his/her spouse’s disease; Partly informed: The patient was
informed about the diagnosis of cancer, but not about the severity of his/her condition; or the SC were partly informed about his/her spouse’s disease
cThe data for the dyad characteristics were reported by the patients
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depression in patients (PCFAC: HAD) was associated with
lower scores for SF-12 PCS (p = 0.002), MCS (p = 0.001),
VT (p = 0.004), and RE (p = 0.000).
Table 4 displays the results of the factors associated
with the HRQOL: SF-12 PCS, MCS, VT, and RE scores
using multiple linear regressions in spousal caregivers.
Two aspects of factors were identified under the sub-
groups of dyads’ characteristics (4c) and HADS (4d). In
dyads’ characteristics (4c), an improved dyadic relation-
ship after the diagnosis of cancer was associated with a
higher score for SF-12 VT (p = 0.005) and a lower score
for SF-12 RE (p = 0.017) when compared with those who
saw no change in their relationship with their partner
after the diagnosis of cancer. Regarding HADS (4d), a
higher level of anxiety and depression in patients
(PCFAC: HAD-P) was only associated with a lower SF-
12 MCS score (p = 0.008); while a higher level of anxiety
and depression in spousal caregivers (PCFAC: HAD of
SC) was associated with lower scores for the spousal
caregivers in the SF-12 domains of PCS (p = 0.001),
MCS (p = 0.001), VT (p = 0.020), and RE (p = 0.001).
Impact of anxiety and depression on HRQOL
APIM was used to test the impact of anxiety and depres-
sion on HRQOL. It was decided that four models will be
analyzed using the two theoretical dimensions of SF-12,
PCS and MCS [41]; and the two data-driven components
that were selected based on the results of this study.
Additional file 2: Figure S1 shows the theoretical APIM
for testing the impact of anxiety and depression on HRQOL.
As shown, anxiety directly or indirectly through depres-
sion impacted on the SF-12 domains as actor effects (from
A-a to A-d) and/or as partner effects (from P-a to P-d) in
the four models, respectively. The SF-12 domains in the
four models (Models 1–4) were: PCS, MCS, VT, and RE.
The APIM analysis of all of the four sub-models
(Additional file 2: Figure S2 and Table 5) resulted in
convergence and showed goodness of fit, with the indi-
ces of Chi-Square χ2 = 2.345, p = 0.310; CFI =0.999; and
RMSEA = 0.036. These good fits to the models of the
APIM analysis provide support for the view that anxiety
and depression are interrelated and have both actor and
partner effects on couples’ health-related quality of life
to various degrees.
A further analysis of the four sub-models using APIM
analysis found that: (1) in general, the impact of anxiety
and depression on HRQOL (PCS, MCS, VT, and RE) was
negative, with five exceptions relating to partner effects
(Additional file 2: Figure S2 and Table 5), including the im-
pact of the patients’ anxiety on their spouses’ PCS, MCS,
and RE; the impact of the spouses’ depression on the pa-
tients’ PCS and VT; (2) one significant actor effect: the pa-
tients’ anxiety on the patients’ MCS; and (3) one significant
partner effect: the patients’ depression on the spouses’ VT.
Discussion
To the best of our knowledge, the present study is the
first attempt in mainland China to examine the HRQOL
Table 2 Scores for HRQOL and HADS: paired samples correlations and differences between patients and spousal caregivers
Paired variables Patients (n = 131) Spousal caregivers (n = 131) r P-value t P-value
Minimum Maximum Mean SD Minimum Maximum Mean SD
Two dimensions of SF-12
PCS 16.26 62.82 37.70 9.46 18.61 61.60 43.05 9.13 0.384 0.000a −5.931 0.000b
MCS 22.85 65.62 41.92 7.18 25.71 62.39 42.25 7.70 0.398 0.000a −0.472 0.638
Eight domains of SF-12
Physical Functioning 22.11 65.05 40.14 10.59 22.11 56.47 42.57 10.89 0.241 0.005a −2.098 0.038b
Role Physical 20.32 57.18 38.01 8.34 20.32 57.18 41.95 9.28 0.088 0.319 −3.782 0.000b
Bodily Pain 16.68 57.44 36.13 13.22 16.68 57.44 42.20 11.54 0.435 0.000a −5.244 0.000b
General Health 18.87 61.99 35.44 11.28 18.87 61.99 41.32 12.58 0.308 0.000a −4.778 0.000b
Vitality 27.62 67.88 44.75 8.89 27.62 67.88 47.21 9.61 0.245 0.005a −2.473 0.015b
Role Emotional 11.35 56.08 34.78 10.68 11.35 56.08 38.11 9.95 0.193 0.027a −2.905 0.004b
Social Functioning 16.18 56.57 39.76 9.75 16.18 56.57 40.92 10.72 0.287 0.001a −1.080 0.282
Mental Health 21.87 64.54 44.21 8.67 15.77 64.54 43.65 9.50 0.368 0.000a 0.624 0.534
HADS
Anxiety 0.00 18.00 7.36 4.00 0.00 19.00 8.52 4.17 0.496 0.000a −3.233 0.002b
Depression 0.00 21.00 6.89 4.48 0.00 21.00 7.95 4.70 0.470 0.000a −2.587 0.011b
HRQOL health-related quality of life, HADS hospital anxiety and depression scales, SD standard deviation, SF-12 the Medical Outcomes Study 12-item Short Form
(MOS SF-12), PCS physical component summary, MCS mental component summary
aSignificant difference in the correlations between paired variables
bSignificant difference in mean scores (paired T-test) between paired variables
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of both advanced cancer patients and their spousal care-
givers. The findings of the study showed the following:
(1) There were small to moderate effect sizes for the as-
sociation between the patients’ HRQOL and that of their
spouses (r = 0.193–0.398). (2) There were multiple inde-
pendent factors influencing the HRQOL (SF-12 PCS,
MCS, VT, and RE) of couples. These included: (i) pa-
tients’ characteristics: gender, length of time since the
diagnosis of cancer; (ii) spousal caregivers’ characteris-
tics: level of education, working status, and being in-
formed about the disease; (iii) characteristics of dyads:
improved dyadic relationship after the diagnosis of can-
cer; and (iv) the anxiety and depression (HADS) of the
couples. Of all of these factors, anxiety and depression
(PCFAC: HAD) had the most influence on the HRQOL
(SF-12 PCS, MCS, VT, and RE) of both patients and
spousal caregivers. Anxiety and depression (PCFAC:
HAD) in patients was not only significantly associated
with all four SF-12 domains (SF-12 PCS, MCS, VT, and
RE) for the patients themselves, but significantly associ-
ated with the SF-12 MCS domain for spousal caregivers.
(3) Anxiety and depression may have both actor and
partner effects on the couples’ HRQOL to various
degrees.
Based on the results of this study, the following three
aspects are discussed: (i) the relationship between the
HRQOL of the advanced cancer patients and that of
their spousal caregivers; and (ii) the factors potentially
contributing to the HRQOL of advanced cancer patients
and their spousal caregivers; and (iii) the impact of anx-
iety and depression on HRQOL.
The relationship between the HRQOL of cancer patients
and that of their spousal caregivers
The findings of this study showed that significant corre-
lations existed in all of the paired variables between the
patients and their spousal caregivers, with the exception
of the “role physical” of SF-12 (r = 0.193–0.398). These
significant correlations may indicate a mutual impact be-
tween the cancer patients and their spousal caregivers in
HRQOL. These correlations between patients and spou-
sal caregivers in QOL were consistent with those found
Table 3 Factors associated with four domains (PCS, MCS, VT, and RE) of the SF-12 of the patients by multiple linear regressions
Independent variables PCS_P MCS_P VT_P RE-P
Coef B (95 % CI) P-value Coef B (95 % CI) P-value Coef B (95 % CI) P-value Coef B (95 % CI) P-value
Constant 44.32(33.47,55.17) 0.000 37.39(29.55,45.23) 0.000 34.68(25.01,44.34) 0.000 32.80(21.80,43.80) 0.000
3a: Patients’ characteristics
Male vs. Female_Pa 2.18(−1.23,5.60) 0.207 −0.56(−3.019,1.91) 0.656 3.40(0.36,6.44) 0.029 −1.98(−5.44,1.48) 0.259
Time since diagnosis of cancer −0.02(−0.09,0.05) 0.533 −0.05(−0.10,0.004) 0.074 −0.07(−0.14,−0.01) 0.020 −0.05(−0.12,0.02) 0.142
Partly vs. Well informed −1.10(−4.87,2.67) 0.565 −1.95(−4.67,0.78) 0.160 0.35(−3.01,3.70) 0.839 −3.02(−6.84,0.80) 0.120
3b: Spousal caregivers’ characteristics
Level of education (vs. University or above)
Primary school 1.06(−4.46,6.57) 0.705 4.79(0.80,8.77) 0.019 3.30(−1.62,8.21) 0.186 8.71(3.12,14.30) 0.003
High school 0.26(−5.14,5.66) 0.925 2.61(−1.29,6.51) 0.187 1.47(−3.34,6.28) 0.546 5.86(0.38,11.33) 0.036
Working vs. Non working 0.83(−2.41,4.07) 0.612 0.93(−1.42,3.27) 0.435 3.28(0.40,6.17) 0.026 0.81(−2.48,4.10) 0.626
Partly vs. Well informed 2.09(−2.18,6.37) 0.334 2.20(−0.89,5.29) 0.161 4.36(0.55, 8.17) 0.025 4.67(0.33, 9.00) 0.035
Time spent in caring for P/day −0.87(−2.12,0.38) 0.172 0.03(−0.87,0.94) 0.945 −0.02(−1.14,1.09) 0.969 −0.44(−1.71,0.83) 0.491
3c: Dyads’ characteristics
Change in the relationship with their partner after the
diagnosis of cancer
Improved vs. No change −0.53(−4.06,2.99) 0.765 −0.91(−3.46,1.64) 0.481 2.90(−0.24,6.04) 0.070 −3.81(−7.39,−0.24) 0.037
Financial burden on the family due to the treatment of cancer
(vs. Mild or None)
Serious −6.23(−14.87,2.42) 0.157 1.20(−5.05,7.45) 0.704 2.77(−4.30,10.48) 0.477 −1.84(−10.61,6.93) 0.678
Normal −4.63(−13.39,4.14) 0.298 2.98(−3.36,9.31) 0.354 4.60(−3.21,12.41) 0.245 1.76(−7.13,10.65) 0.696
3d: HADS
PCFAC: HAD of patients −3.00(−4.90,−1.10) 0.002 −2.40(−3.77,-1.03) 0.001 −2.49(−4.18,−0.80) 0.004 −3.54(−5.47,−1.61) 0.000
PCFAC: HAD of SC −0.51(−2.39,1.37) 0.594 −0.80(−2.16,0.56) 0.248 −0.37(−2.05,1.31) 0.662 −1.53(−3.44,0.38) 0.115
PCS physical component summary, MCS mental component summary, VT vitality, RE role emotional, P patient, SC spousal caregivers; Coef B unstandardized
regression coefficient B; CI confidence interval, PCFAC: HAD principal component from factor analysis of anxiety and depression
aThe findings in the gender analysis of the patients are the opposite of those in the gender analysis of spousal caregivers
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in other studies. A study showed that the total QOL
score of the patients was associated with both the total
score and the score for each dimension of the QOL of
their spousal caregivers (r = 0.27–0.44) [4]. Another lon-
gitudinal study of patients with prostate cancer and their
spouses also reported small to moderately significant
correlations in QOL between the patients and their
spouses over time (r = 0.25, 0.24, 0.23, and 0.23 at base-
line, and at the 4-, 8-, and 12- month follow-ups respect-
ively) [14].
The HRQOL of the couples coping with cancer in this
study in Wuxi revealed that the PCS of the patients
(37.70 + 9.49) and the spousal caregivers (43.05 + 9.13),
and the MCS of the patients (41.92 + 7.18) and the spou-
sal caregivers (42.25 + 7.70), were lower than those of a
sample of the general population of urban Chengdu city
(n = 1365) in China (PCS = 51.2 + 6.6, MCS = 49.9 + 7.7)
[42]. The results also showed that spousal caregivers had
higher scores than the patients in most of the subscales
of SF-12 (with the exception of MCS, SF, and MH). This
may be because the patients were suffering from the
cancer and its treatment, particularly from the side-
effects of chemotherapy. However, it should be noted
that mental health was the only domain of SF-12 in
which the spousal caregivers had lower scores than the
patients, although no significant difference was identi-
fied. This finding may partly echo previous evidence in-
dicating that the emotional distress of spousal caregivers
may be as great as or even greater than that of the pa-
tients themselves [13, 43].
The finding in the present study that the RE score was
the lowest among all of the SF-12 domains and dimen-
sions is partly consistent with the finding of another
study, which examined the HRQOL and related factors
of Chinese patients undergoing chemotherapy for ad-
vanced cancer [23]. The HRQOL of cancer patients in
that study was assessed using both the SF-36 and the
European Organization for the Research and Treatment
of Cancer’s quality of life questionnaire (EORTC QLQ-
C30). The study also identified that RP and RE as
Table 4 Factors associated with four domains (PCS, MCS, VT, and RE) of the SF-12 of the spousal caregivers by multiple linear
regressions
Independent variables PCS_SC MCS_SC VT_SC RE-SC
Coef B (95 % CI) P-value Coef B (95 % CI) P-value Coef B (95 % CI) P-value Coef B (95 % CI) P-value
Constant 50.36(39.92,60.81) 0.000 43.37(34.92,51.82) 0.000 52.83(41.75,63.92) 0.000 44.20(33.26,55.13) 0.000
4a: Patients’ characteristics
Male vs. Female_Pa 0.27(−3.01,3.55) 0.871 0.02(−2.63,2.68) 0.987 0.92(−2.57,4.40) 0.603 1.16(−2.28,4.60) 0.505
Time since diagnosis of cancer −0.03(−0.09,0.04) 0.458 −0.01(−0.06,0.05) 0.786 −0.01(−0.08,0.06) 0.730 −0.004(−0.07,0.07) 0.906
Partly vs. Well informed −0.97(−4.60,2.66) 0.598 0.69(−2.25,3.63) 0.643 2.01(−1.84,5.86) 0.303 1.77(−2.03,5.57) 0.357
4b: Spousal caregivers’ characteristics
Level of education (vs. University or above)
Primary school 0.48(−4.83,5.79) 0.858 −0.67(−4.96,3.63) 0.758 −1.35(−6.99,4.28) 0.636 1.48(−4.08,7.04) 0.600
High school 0.15(−5.05,5.35) 0.955 −0.51(−4.71,3.70) 0.812 −1.22(−6.74,4.30) 0.663 1.75(−3.69,7.19) 0.525
Working vs. Non working 0.42(−2.70,3.54) 0.790 −0.22(−2.74,2.31) 0.865 0.57(−2.74,3.88) 0.732 0.88(−2.38,4.15) 0.593
Partly vs. Well informed −1.55(−5.67,2.56) 0.457 1.62(−1.71,4.95) 0.336 1.08(−3.29,5.44) 0.627 −3.29(−7.60,1.02) 0.133
Time spent in caring for P/day 0.09(−1.11,1.30) 0.880 −0.50(−1.48,0.47) 0.310 −0.94(−2.22,0.33) 0.146 −0.36(−1.62,0.91) 0.578
4c: Dyads’ characteristics
Change in the relationship with their partner after the
diagnosis of cancer
Improved vs. No change 0.22(−3.17,3.62) 0.898 −0.80(−3.55,1.95) 0.565 5.18(1.57,8.78) 0.005 −4.36(−7.92,−0.81) 0.017
Financial burden on the family due to the treatment of cancer
(vs. Mild or None)
Serious −8.29(−16.62,0.04) 0.061 1.00(−5.73,7.74) 0.769 −4.13(−12.96,4.71) 0.357 −7.54(−16.26,1.17) 0.089
Normal −7.15(−15.59,1.29) 0.096 1.92(−4.91,8.74) 0.580 −3.59(−12.54,5.37) 0.429 −3.79(−12.63,5.04) 0.397
4d: HADS
PCFAC: HAD of patients −0.68(−2.51,1.15) 0.464 −2.00(−3.48,−0.52) 0.008 −0.79(−2.73,1.15) 0.422 −1.33(−3.25,0.58) 0.171
PCFAC: HAD of SC −3.09(−4.90,−1.27) 0.001 −2.51(−3.97,−1.04) 0.001 −2.29(−4.22,−0.37) 0.020 −3.18(−5.08,−1.29) 0.001
PCS physical component summary, MCS mental component summary, VT vitality, RE role emotional, P patient; SC Spousal Caregivers; Coef B Unstandardized
regression Coefficient B, CI confidence interval, PCFAC: HAD principal component from a factor analysis of anxiety and depression
aThe findings of the gender analysis of the patients are the opposite of those in the gender analysis of the spousal caregivers
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measured by SF-36, and role functioning as measured by
EORTC QLQ-C30 had the lowest scores among the do-
mains of the instruments. These consistent findings on
the scores on role functioning in cancer patients using
different instruments should attract attention to this as-
pect of the QOL of cancer patients. Indeed, cancer and
its treatment pose challenges to couples, in that they
find it necessary to readjust and adapt to changes in
both their family and occupational roles [6, 8, 9].
The factors contributing to the HRQOL of cancer patients
and spousal caregivers
Multiple independent factors contributing to HRQOL
(SF-12 PCS, MCS, VT, and RE) were identified in the
present analysis using multiple linear regressions, includ-
ing those for gender, time since the diagnosis of cancer,
level of education of the spousal caregivers, the spouses’
working status, the extent to which the spousal care-
givers were informed about the disease, the dyadic rela-
tionship after the diagnosis of cancer, and anxiety and
depression.
Patients’ characteristics
This study found that male patients (female spousal
caregivers) had higher SF-12 VT scores. Evidence is
accumulating that there are gender differences in how
the partners in a couple experience coping with cancer
[44]. A review that explored the experiences of spousal
caregivers caring for cancer patients from the perspec-
tive of gender revealed that female caregivers of spouses
with cancer experienced higher negative impacts in
many different dimensions when compared to their male
counterparts, such as poorer mental health, physical
health, HRQOL, life satisfaction, and marital adjustment
[45]. A study of cancer patients and spousal caregivers
showed that female spousal caregivers of cancer patients
are more likely to experience personal growth than
males in terms of being open to new possibilities, relat-
ing to others, appreciating life, finding personal strength,
and experiencing spiritual change [46].
One reason for the differences between female and male
caregivers may lie in the differences in gender role com-
mitment [47]. Female caregivers of cancer patients have
been found to position themselves as all-encompassing
expert caregivers, taking on too many responsibilities and
sacrificing themselves, leading to distress, in contrast to
male caregivers who see caring as a task of competency
(not their traditional role), leading to feelings of self-
mastery or satisfaction [48, 49]. Female caregivers are
traditionally more likely to perform personal care in
Table 5 Standardized path coefficients and fit statistics of four models
Indicates M 1 M 2 M 3 M 4
Dyadic variables PCS MCS VT RE
Number of distinct sample moments: 27 27 27 27
Number of distinct parameters to be estimated 25 25 25 25
Degrees of freedom 2 2 2 2
Anxiety_P Depression_P 0.82** 0.82** 0.82** 0.82**
Anxiety_SC Depression_SC 0.83** 0.83** 0.83** 0.83**
Anxiety _P SDs_P (A-a) −0.14 −0.32* −0.02 −0.21
Anxiety _P SDs_SC (P-a) 0.06 −0.09 0.26 0.002
Depression_P SDs_P (A-b) −0.22 −0.02 −0.23 −0.12
Depression_P SDs_SC (P-b) −0.16 −0.18 −0.33* −0.22
Anxiety_SC SDs_SC (A-c) −0.13 −0.18 −0.08 −0.24
Anxiety_SC SDs_P (P-c) −0.16 −0.05 −0.11 −0.18
Depression_SC SDs_SC (A-d) −0.22 −0.16 −0.25 −0.07
Depression_SC SDs_P (P-d) 0.03 −0.12 0.01 −0.03
Chi-square X2 2.345 2.345 2.345 2.345
Probability level (P > 0.05) 0. 310 0. 310 0. 310 0. 310
a confirmatory fit index (CFI > 0.95) 0.999 0.999 0.999 0.999
a root mean square error of approximation (RMSEA < 0.08) 0.036 0.036 0.036 0.036
SDs SF-12 Domains, P patients, SC spousal caregivers
A-a, A-b, A-c, A-d, A-d stands for Actor effects
P-a, P-b, P-c, P-d stands for Partner effects
M1 to M4 represent four different sub-models. M1: PCS = physical component summary; M2: MCS =mental component summary; M3: VT = Vitality; M4:
RE = role emotional
*P < 0.05; **P < 0.01
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relation to family members and household chores, which
may be more demanding and ongoing than traditional
male tasks [48].
A longer duration since the diagnosis of cancer was
found to be associated with lower SF-12 VT scores for
patients. This finding was inconsistent with another
study, which found no significant association between
the diagnosis and duration of cancer and the wellbeing
of caregivers [50].
Spousal caregivers’ characteristics
The characteristics of spousal caregivers, such as level of
education, working status, and being informed about the
disease, were identified as being related to the HRQOL
of the patients. These findings again indicate that there
is a mutual impact between cancer patients and spousal
caregivers with regard to their HRQOL. No similar
quantitative study on this aspect was identified. This was
supported by the findings of a focus group study on the
experiences of Chinese couples living with cancer. The
findings showed that providing the patients and/or their
spousal caregivers with accurate information about their
illness, as well as an appropriate amount of information
and at the right time, could improve their experience of
living with cancer [51].
Dyad characteristics
In this study, about one-third (29.0 %) of the couples
(87.8 %) reported that their relationship with their part-
ner improved after the diagnosis of cancer. This relation-
ship dynamic was echoed in a literature review, which
found that caregivers reported that their relationship
with the care-receiver had improved because of the care-
giving process [52]. The caregivers experienced stronger
feelings of love and of being closer together, resulting in
an enhanced and deeper relationship with the care-
receiver [53, 54].
The results of this study also showed that an improved
dyadic relationship after the diagnosis of cancer was as-
sociated with a lower score for SF-12 RE in both patients
and spousal caregivers, and a higher score for SF-12 VT
in spousal caregivers. The association between improved
dyadic relationship and lower role emotional (RE)
pointed to the fact that couples with an improved dyadic
relationship were able to use problem-focused coping
and/or meaning-focused coping, rather than emotion-
focused coping. This demonstrated that these couples
were coping effectively, thus leading to the higher VT. A
framework on the positive aspects of caregiving illus-
trated that an improved relationship between caregivers
and care-receivers with dementia (spousal caregivers and
patients with cancer in this case) could benefit the well-
being of the caregivers and support their continued in-
volvement in the caregiving process [55].
The association between the QOL of a couple and
their relationship with each other was also supported by
other studies. For instance, the level of marital satisfac-
tion was found to be one of the strongest factors influ-
encing whether a spousal caregiver would have problems
performing the caregiving role [13]; and dyadic adjust-
ment was associated with a spouse’s mood disturbances
(r = −0.49, P = 0.001) and mental health functioning (r =
0.35, P = 0.02) [56]. Both the mental (r = 0.33, P < 0.05)
and physical (r = 0.28, P < 0.05) health of patients was
positively related to their caregiver’s marital satisfaction
[57]. This finding is a reminder that improving the rela-
tionship of couples may be an effective method of en-
hancing the couples’ HRQOL in their journey of coping
with cancer together. Indeed, a review of spousal couple-
based intervention studies revealed that intervention
studies focusing on marital/family care showed positive
outcomes, including improvements in communication,
dyadic coping, and in the QOL of both the patients and
their partners [58].
Anxiety and depression
Anxiety and depression were identified as the strongest
independent factors influencing the HRQOL (SF-12
PCS, MCS, VT, and RE) of both the patients and spousal
caregivers in this study. A high level of anxiety and de-
pression (PCFAC: HAD) in spousal caregivers was sig-
nificantly associated with all of the four SF-12 scores
(PCS, MCS, VT, and RE) of the spousal caregivers. A
high level of anxiety and depression (PCFAC: HAD) in
patients was also significantly associated with all of the
four SF-12 domains (PCS, MCS, VT, and RE) of the pa-
tients and with the SF-12 MCS domain of their spousal
caregivers. These findings are consistent with those of
previous studies, in that higher levels of anxiety and de-
pression have generally been associated with poorer
HRQOL in cancer patients [59–61]. An intervention
study has reported that efforts to manage depression
had a positive impact on improving the HRQOL of can-
cer patients [62].
Impact of anxiety and depression on HRQOL
An APIM analysis showed that all of the four sub-
models resulted in convergence and showed goodness of
fit. These findings support the view that anxiety directly
or indirectly through depression impacted on the SF-12
domains as actor effects and/or as partner effects in the
four detected models. These findings also support the
argument that couples have a mutual impact on each
other in their journey of coping with cancer together.
In addition, the general negative impact of anxiety and
depression on the couples’ HRQOL as revealed in the
APIM analysis further supports and is consistent with
the findings from the multiple linear regressions, in that
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anxiety and depression were the strongest independent
factors influencing the HRQOL (SF-12 PCS, MCS, VT,
and RE) of both the patients and their spousal caregivers.
However, it is worth noting that only one significant actor
effect (patients’ anxiety on patients’ MCS), and one signifi-
cant partner effect (patients’ depression on spouses’ VT)
were identified. There were five exceptions to the trend of
positive impacts on partner effects, including the impact
of the patients’ anxiety on their spouses’ PCS, MCS, and
RE; and the impact of the spouses’ depression on the pa-
tients’ PCS, and VT (Table 5). These findings revealed
that, to a certain extent, the distress of the couples, e.g.,
the patients’ anxiety and their spouses’ depression, may
motivate the couples to cope with cancer as dyads, or have
a positive impact on the couples’ HRQOL. These findings
also indicated that the impact of both the patients’ and
their spouses’ anxiety and depression on the couples’
HRQOL is complicated and deserves further exploration,
particularly at the dyadic level.
In summary, the results of this study showed that the
couples’ HRQOL was relatively low, and that there was a
mutual impact between the cancer patients and their
spousal caregivers in various aspects of HRQOL. The
factors that were identified as possibly affecting the
HRQOL of couples can be grouped into three main as-
pects: (1) individual characteristics of the patients and
their spousal caregivers: male patients, female spousal
caregivers, shorter duration since the diagnosis of cancer,
lower level of education of spousal caregivers, spouses
who hold a full-time job, spouses who are partly in-
formed about the disease; (2) dyadic characteristic: im-
proved dyadic relationship after the diagnosis of cancer;
and (3) the couples’ distress: a lower level of anxiety and
depression in both the cancer patients and their spouses.
The multiple factors that were identified as influencing
the couples’ HRQOL provide valuable evidence of the
components that need to be included in any intervention
to improve the HRQOL of couples. Health care profes-
sionals, when working with couples coping with cancer,
should pay special attention not only to the HRQOL of
cancer patients, but also to providing support to their
spousal caregivers, who are accompanying their loved
ones through the cancer trajectory. To improve the
HRQOL of couples in cancer practice, clinicians need to
pay more attention to multiple aspects, including to de-
veloping and delivering the intervention as early as pos-
sible, to paying special attention to the characteristics of
both the patients and their spouses, to enhancing the
couple’s relationship, and to helping couples to manage
their distress, e.g., anxiety or depression.
Strengths and limitations
The main strength of the present study was the dyadic
data obtained from both the cancer patients and their
spousal caregivers. The dyadic data made it possible to
explore the mutual impact between the couples; and it
also made it possible to analyze factors of potential im-
pact from different aspects, including the characteristics
of the patients, spousal caregivers, and dyads.
The findings of the study contribute to the under-
standing of the HRQOL of Chinese couples in their
journey of coping with cancer as a dyad; however, it is
not without limitations. The study was limited by its
cross-sectional design, and the conclusions that were
drawn need to be confirmed in future studies. Moreover,
the fact that the study population was comprised of pa-
tients with advanced cancer undergoing chemotherapy
in an oncology hospital in Wuxi, China, may mean that
the results are not generalizable to couples in other
stages of cancer, out-patients, and those living in other
countries. Also, the heterogeneity of the subjects, who
suffered from different types of cancer, might have af-
fected the attempt to measure levels of HRQOL. A large
sample study on the impact of different types of cancer
and different stages of cancer on HRQOL is needed.
In addition, this study contained a relatively small
sample for testing APIM models, barely meeting the
critical minimum number for the target population to be
tested for medium to large effects using APIM [63]. One
should therefore interpret the results of this study with
caution. Until this study is replicated with larger samples,
its findings can only be taken as suggestive [64], p. 72). Fu-
ture studies involving larger sample sizes for APIM ana-
lysis are highly recommended.
Another limitation lies in the fact that the HRQOL of
couples coping with cancer was measured using the SF-
12. As a generic measure, the SF-12 might not be suffi-
ciently sensitive or specific to evaluate the HRQOL of
advanced cancer patients and spousal caregivers. The
application of both generic and specific measures of
HRQOL for couples coping with cancer is needed. How-
ever, the choice of SF-12 fits the aim in this study of
assessing the QOL of both the patients and their spousal
caregivers. It also made it possible to compare the
HRQOL outcomes of the two parties.
Conclusion
Notwithstanding these limitations, the findings of this
study call for attention to be paid to HRQOL and its re-
lated factors for couples coping with cancer as dyads. It
highlights the following as areas in which couples coping
with advanced cancer could benefit from interventions
to improve their HRQOL: individual characteristics of
both the cancer patients and their spouses, their marital
relationship, and their anxiety and depression. Indeed,
the evidence showed that interventions to improve the
marital relationship of the couples [58] and their ability
to manage depression [62] were effective at improving
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the HRQOL of couples or cancer patients. In addition,
the mutual impact between the cancer patients and their
spousal caregivers should alert clinicians to the import-
ance of treating couples as a dyad when delivering inter-
ventions to improve the HRQOL of patients and spouses.
The complex impact of anxiety and depression on the
HRQOL of couples is an area that deserves further investi-
gation in cancer practice.
Additional files
Additional file 1: Table S1. Association between the variables of both
the patients and their spousal caregivers and the PCS, MCS, VT, and RE
domains of the SF-12 of the patients. Table S2. Association between the
variables of both the patients and spousal caregivers and the PCS, MCS,
VT, and RE domains of the SF-12 of the spousal caregivers. (DOC 293 kb)
Additional file 2: Figure S1. Theoretical model in testing the impact of
anxiety and depression on Health related quality of life. Figure S2. Four
sub-models (sub-model 1-4) for testing testing the impact of anxiey and
depression on HRQOL. (DOC 475 kb)
Abbreviations
BP, bodily pain; GH, general health; HADS, hospital anxiety and depression
scale; HRQOL, health related quality of life; MCS, the Mental Component
Summary; MH, mental health; PCS, the Physical Component Summary; PF,
physical functioning; RE, role-emotional; RP, role-physical; SEM, structural
equation modeling; SF, social functioning; SF-12, the Medical Outcomes
Study 12-item Short Form; VT, vitality
Acknowledgments
The authors gratefully acknowledge the support that they have received
from the hospital. Our special thanks to all of the participants and nurses in
this study. The authors are also grateful to two reviewers for their very
helpful comments on a previous version of this manuscript.
Funding
The authors declare that no funding for the research was received.
Availability of data and materials
The dataset(s) supporting the conclusions of this article is (are) available and
will be provided by the authors upon request.
Authors' contributions
All of the authors contributed substantially to this manuscript. The first author
(QL) participated in the design of the study, carried out the data collection/
analysis, and drafted the manuscript. The second and third authors (YX and HZ)
also made substantial contributions to collecting data and writing the
manuscript. The last author (AL) supervised the study, participated in its design
and coordination, and made critical revisions for important intellectual content.
All of the authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethical approval and consent to participate
Before the commencement of the study, ethical approval for the study was
granted by the research ethics committee of Jiangnan University. Informed
written consent was obtained from the participants prior to the study.
Author details
1Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu Province, China.
2Wuxi People’s Hospital, Wuxi, Jiangsu Province, China. 3School of Nursing,
The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong,
China.
Received: 2 December 2015 Accepted: 27 July 2016
References
1. WHO. WHO | cancer fact sheet N°297. 2015. Retrieved from [http://www.
who.int/mediacentre/factsheets/fs297/en/index.html]. Accessed 8 Aug 2015.
2. López-Gómez M, Malmierca E, de Górgolas M, Casado E. Cancer in
developing countries: The next most preventable pandemic. The global
problem of cancer. Crit Rev Oncol. 2013;88:117–22.
3. Kayser KP, Watson LEM, Licsw, Andrade JTM. Cancer as a "We-Disease":
Examining the Process of Coping From a Relational Perspective. Fam Syst
Health. 2007;25(4):404–18.
4. Chen ML, Chu L, Chen HC. Impact of cancer patients' quality of life on that
of spouse caregivers. Support Care Cancer. 2004;12(7):469–75.
5. O'Connor AP, Wicker CA, Germino BB. Understanding the cancer patient's
search for meaning. Cancer Nurs. 1990;13(3):167–75.
6. Maughan K, Heyman B, Matthews M. In the shadow of risk. How men cope
with a partner's gynaecological cancer. Int J Nurs Stud. 2002;39(1):27–34.
7. Thomas C, Morris SM, Harman JC. Companions through cancer: The care
given by informal carers in cancer contexts. Soc Sci Med. 2002;54(4):529–44.
8. Lopez V, Copp G, Molassiotis A. Male caregivers of patients with breast and
gynecologic cancer: Experiences from caring for their spouses and partners.
Cancer Nurs. 2012;35(6):402–10.
9. Harden J. Developmental life stage and couples' experiences with prostate
cancer - A review of the literature. Cancer Nurs. 2005;28(2):85–98.
10. Li Q, Loke AY. A literature review on the mutual impact of the spousal
caregiver-cancer patients dyads: ‘communication’, ‘reciprocal influence’, and
‘caregiver-patient congruence’. Eur J Oncol Nurs. 2014;18(1):58–65.
11. Dankoski ME, Pais S. What's love got to do with it? Couples, illness, and
MFT. Journal of Couple and Relationship Therapy. 2007;6(1–2):31–43.
12. Kim Y, Kashy DA, Wellisch DK, Spillers RL, Kaw CK, Smith TG. Quality of life
of couples dealing with cancer: Dyadic and individual adjustment among
breast and prostate cancer survivors and their spousal caregivers. Ann
Behav Med. 2008;35(2):230–8.
13. Northouse LL, Mood D, Templin T, Mellon S, George T. Couples' patterns of
adjustment to colon cancer. Soc Sci Med. 2000;50(2):271–84.
14. Song L, Northouse LL, Braun TM, Zhang L, Cimprich B, Ronis DL, Mood DW.
Assessing longitudinal quality of life in prostate cancer patients and their
spouses: a multilevel modeling approach. Qual Life Res. 2011;20(3):371–81.
15. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-
and-pencil administration of patient-reported outcome measures: A meta-
analytic review. Value Health. 2008;11(2):322–33.
16. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of
patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26(8):1355–63.
17. Blum K, Sherman DW. Understanding the experience of caregivers: a focus
on transitions. Semin Oncol Nurs. 2010;26(4):243–58.
18. Liu C, Ren H, Li J, Li X, Dai Y, Liu L, Ma L, He Q, Li X. Predictors for quality of
life of bladder cancer patients with ileal conduit: A cross-sectional survey.
Eur J Oncol Nurs. 2016;21:168–73.
19. Wu SF, Tong HY, Kan YY, Su SH, Lee MC, Kao CC, Lin YH. The Exploration of
Health-Related Quality of Life: Factors Influencing Quality of Life in
Gynecologic Cancer Patients. Clin Nurs Res 2015. [Epub ahead of print].
20. Hong JS, Tian J, Han QF, Ni QY. Quality of life of nasopharyngeal cancer
survivors in China. Curr Oncol. 2015;22(3):e142–7.
21. Shen FR, Liu M, Zhang X, Feng YH, Zhou LS, Chen YG. Health-related quality
of life among breast cancer patients and its influencing factor in a Chinese
population. Asian Pac J Cancer Prev. 2012;13(8):3747–50.
22. Heydarnejad MS, Hassanpour DA, Solati DK. Factors affecting quality of life in
cancer patients undergoing chemotherapy. Afr Health Sci. 2011;11(2):266–70.
23. Li Q, Lin Y, Qiu Y, Gao B, Xu Y. The assessment of health-related quality of life
and related factors in Chinese elderly patients undergoing chemotherapy for
advanced cancer: A cross-sectional study. Eur J Oncol Nurs. 2014;18(4):425–35.
24. Song L, Ji Y, Nielsen ME. Quality of life and health status among prostate cancer
survivors and noncancer population controls. Urology. 2014;83(3):658–63.
25. Zhu P, Fu JF, Wang B, Lin J, Wang Y, Fang NN, Wang DD. Quality of life of
male spouse caregivers for breast cancer patients in China. Asian Pac J
Cancer Prev. 2014;15(10):4181–5.
26. Effendy C, Vernooij-Dassen M, Setiyarini S, Kristanti MS, Tejawinata S, Vissers
K, Engels Y. Family caregivers' involvement in caring for a hospitalized
patient with cancer and their quality of life in a country with strong family
bonds. Psychooncology. 2015;24(5):585–91.
Li et al. BMC Palliative Care  (2016) 15:72 Page 13 of 14
27. Lu L, Pan B, Sun W, Cheng L, Chi T, Wang L. Quality of life and related
factors among cancer caregivers in China. Psychiatry Clin Neurosci.
2010;64(5):505–13.
28. Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: A flexible statistical
power analysis program for the social, behavioral, and biomedical sciences.
Behav Res Methods. 2007;39(2):175–91.
29. Portney LG, Watkins MP. Foundations of clinical research. 3rd ed. London:
Pearson/Prentice Hall; 2009.
30. Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34(3):220–33.
31. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta
Psychiatr Scand. 1983;67(6):361–70.
32. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to score version 2
of the SF-12 health survey (with a supplement documenting version 1).
QualityMetric Incorporated; 2002.
33. Li L, Wang H, Shen Y. Chinese SF-36 Health Survey: translation, cultural
adaptation, validation, and normalisation. J Epidemiol Community Health.
2003;57(4):259–63.
34. Lam ET, Lam CL, Fong DY, Huang WW. Is the SF-12 version 2 Health Survey
a valid and equivalent substitute for the SF-36 version 2 Health Survey for
the Chinese? J Eval Clin Pract. 2013;19(1):200–8.
35. Shou J, Ren L, Wang H, Yan F, Cao X, Wang H, Wang Z, Zhu S, Liu Y.
Reliability and validity of 12-item Short-Form health survey (SF-12) for the
health status of Chinese community elderly population in Xujiahui district
of Shanghai. Aging Clin Exp Res. 2016;28(2):339–46.
36. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital
Anxiety and Depression Scale: an updated literature review. J Psychosom
Res. 2002;52(2):69–77.
37. Leung CM, Ho S, Kan CS, Hung CH, Chen CN. Evaluation of the Chinese
version of the Hospital Anxiety and Depression Scale. A cross-cultural
perspective. Int J Psychosom. 1993;40(1–4):29–34.
38. Leung CM, Wing YK, Kwong P, Shum ALK. Validation of the Chinese‐
Cantonese version of the Hospital Anxiety and Depression Scale and
comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr
Scand. 1999;100(6):456–61.
39. Atkins DC. Using multilevel models to analyze couple and family treatment
data: basic and advanced issues. J Fam Psychol. 2005;19(1):98–110.
40. Hooper D, Coughlan J, Mullen M. Structural Equation Modeling: Guidelines
for Determining Model Fit. Journal of Business Research Methods.
2008;6(1):53–60.
41. Michalsen VL, Vandvik PO, Farup PG. Predictors of health-related quality of
life in patients with irritable bowel syndrome. A cross-sectional study in
Norway. Health Qual Life Outcomes. 2015;13(1):113.
42. Li NX, Liu DP, Liu CJ, Ren XH, Gao B. Assessing quality of life in an urban
population in Chengdu using the SF-12. Sichuan Da Xue Xue Bao Yi Xue
Ban. 2010;41(6):1044–6.
43. Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC. Distress in
couples coping with cancer: a meta-analysis and critical review of role and
gender effects. Psychol Bull. 2008;134(1):1–30.
44. Li Q, Loke AY. A spectrum of hidden morbidities among spousal caregivers
for patients with cancer, and differences between the genders: A review of
the literature. Eur J Oncol Nurs. 2013;17(5):578–87.
45. Li Q, Mak YW, Loke AY. Spouses' experience of caregiving for cancer
patients: A literature review. Int Nurs Rev. 2013;60(2):178–87.
46. Zwahlen D, Hagenbuch N, Carley MI, Jenewein J, Buchi S. Posttraumatic growth
in cancer patients and partners - Effects of role, gender and the dyad on
couples' posttraumatic growth experience. Psychooncology. 2010;19(1):12–20.
47. Kramer BJ, Kipnis S. Eldercare and work-role conflict: toward an understanding
of gender differences in caregiver burden. Gerontologist. 1995;35(3):340–8.
48. Kim Y, Baker F, Spillers RL. Cancer caregivers' quality of life: effects of
gender, relationship, and appraisal. Journal of Pain & Symptom
Management. 2007;34(3):294–304.
49. Ussher JM, Sandoval M. Gender differences in the construction and
experience of cancer care: The consequences of the gendered positioning
of carers. Psychol Health. 2008;23(8):945–63.
50. Nijboer C, Tempelaar R, Triemstra M, Sanderman R, van den Bos G.
Dynamics in cancer caregiver's health over time: Gender-specific patterns
and determinants. Psychol Health. 2001;16(4):471–88.
51. Li Q, Chiang VCL, Xu X, Xu Y, Loke AY. The Experiences of Couples Living
with Cancer: A Focus Group Study. Cancer Nurs. 2015;38(5):383–94.
52. Li Q, Loke AY. The positive aspects of caregiving for cancer patients: a
critical review of the literature and directions for future research.
Psychooncology. 2013;22(11):2399–407.
53. Ussher JM, Tim Wong WK, Perz J. A qualitative analysis of changes in
relationship dynamics and roles between people with cancer and their
primary informal carer. Health: an Interdisciplinary Journal for the Social
Study of Health, Illness & Medicine. 2011;15(6):650–67.
54. Wong WKT, Ussher J. Bereaved informal cancer carers making sense of their
palliative care experiences at home. Health Soc Care Community.
2009;17(3):274–82.
55. Carbonneau H, Caron C, Desrosiers J. Development of a conceptual framework
of positive aspects of caregiving in dementia. Dementia. 2010;9(3):327–53.
56. Sterba KR, Swartz RJ, Basen-Engquist K, Black PC, Pettaway CA. Long-term
quality of life after radical prostatectomy in wives of men in the
postoperative adjuvant androgen deprivation trial. Support Care Cancer.
2011;19(8):1117–24.
57. Zhou ES, Kim Y, Rasheed M, Benedict C, Bustillo NE, Soloway M, Kava BR,
Penedo FJ. Marital satisfaction of advanced prostate cancer survivors and
their spousal caregivers: the dyadic effects of physical and mental health.
Psychooncology. 2011;20(12):1353–7.
58. Li Q, Loke AY. A systematic review of spousal couple-based intervention
studies for couples coping with cancer: direction for the development of
interventions. Psychooncology. 2014;23(7):731–9.
59. Shim E, Mehnert A, Koyama A, Cho S, Inui H, Paik N, Koch U. Health-related
quality of life in breast cancer: A cross-cultural survey of German, Japanese,
and South Korean patients. Breast Cancer Res Treat. 2006;99(3):341–50.
60. Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M.
Depression and anxiety levels in woman under follow-up for breast cancer:
relationship to coping with cancer and quality of life. Med Oncol.
2010;27(1):108–13.
61. Smith E, Gomm S, Dickens C. Assessing the independent contribution to
quality of life from anxiety and depression in patients with advanced
cancer. Palliat Med. 2003;17(6):509–13.
62. Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, McHugh G, Walker
A, Sharpe M. Management of depression for people with cancer (SMaRT
oncology 1): A randomised trial. Lancet. 2008;372(9632):40–8.
63. Dorros SM, Card NA, Segrin C, Badger TA. Interdependence in Women With
Breast Cancer and Their Partners: An Interindividual Model of Distress.
J Consult Clin Psychol. 2010;78(1):121–5.
64. Hoyle RH. Structural equation modeling for social and personality
psychology. 1st ed. SAGE Publications Ltd; 2011.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Li et al. BMC Palliative Care  (2016) 15:72 Page 14 of 14
